Matthias Kromayer

Chief Executive Officer at

Tavia Consulting GmbH

61 year

34 connections

Health Technology

Consumer Services

Finance

Profile

Matthias Kromayer currently works at BIOCRATES Life Sciences AG, as Deputy Chairman-Supervisory Board, AMSilk GmbH, as Vice Chairman-Supervisory Board, Immatics US, Inc., as Director, Tavia Consulting GmbH, as Managing Director, MIG Verwaltungs AG, as Managing Partner from 2010, Ci3 Management UG, as Member, Minaris Regenerative Medicine GmbH, as Member-Supervisory Board, and iOmx Therapeutics AG, as Member-Supervisory Board from 2022.
Dr. Kromayer also formerly worked at ViroLogik GmbH, as Chief Executive Officer, cerbomed GmbH, as Chairman, Nexigen GmbH, as Chairman-Advisory Board & Director, Immatics Biotechnologies GmbH, as Member-Supervisory Board in 2013, and BRAIN Biotech AG, as Member-Supervisory Board from 2011 to 2017.
Dr. Kromayer received his doctorate degree from Ludwig-Maximilians-Universität München.

Matthias Kromayer active positions

Companies	Position	Start
MIG Verwaltungs AG MIG Verwaltungs AG Investment ManagersFinance MIG Capital seeks investment opportunities in companies located in Europe. The firm focuses on deep tech and life science sectors. It provides financing for early stage capital requirements with an investment size ranging from EURO 1-10 million.	Private Equity Investor	09/02/2010
AMSilk GmbH AMSilk GmbH TextilesProcess Industries Produces biotech materials	Director/Board Member	-
Tavia Consulting GmbH	Chief Executive Officer	-
BIOCRATES Life Sciences AG BIOCRATES Life Sciences AG Medical SpecialtiesHealth Technology Operates as a mass spectrometry-based quantitative metabolite analysis	Director/Board Member	-
Ci3 Management UG	Corporate Officer/Principal	-
Immatics US, Inc. Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer	Director/Board Member	-
Minaris Regenerative Medicine GmbH Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology Develops cell-based and gene therapy products	Director/Board Member	-
iOmx Therapeutics AG iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients	Director/Board Member	20/07/2022

All active positions of Matthias Kromayer

Former positions of Matthias Kromayer

Companies	Position	End
BRAIN BIOTECH AG	Director/Board Member	09/03/2017
░░░░░░░░ ░░░░	░░░░░░░░	-
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░░ ░░░░	░░░░░░░░	-
░░░░░░░░░ ░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	-

See the detail of Matthias Kromayer's experience

Training of Matthias Kromayer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthias Kromayer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Immatics Biotechnologies GmbH Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MIG Verwaltungs AG MIG Verwaltungs AG Investment ManagersFinance MIG Capital seeks investment opportunities in companies located in Europe. The firm focuses on deep tech and life science sectors. It provides financing for early stage capital requirements with an investment size ranging from EURO 1-10 million.	Finance
BRAIN Biotech AG BRAIN Biotech AG BiotechnologyHealth Technology Discovers and develops bioactive natural compounds and proprietary enzymes	Health Technology
ViroLogik GmbH ViroLogik GmbH Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of viral diseases	Health Technology
cerbomed GmbH cerbomed GmbH Medical SpecialtiesHealth Technology Manufactures and supplies medical devices for treating epilepsy	Health Technology
BIOCRATES Life Sciences AG BIOCRATES Life Sciences AG Medical SpecialtiesHealth Technology Operates as a mass spectrometry-based quantitative metabolite analysis	Health Technology
AMSilk GmbH AMSilk GmbH TextilesProcess Industries Produces biotech materials	Process Industries
Nexigen GmbH Nexigen GmbH Pharmaceuticals: MajorHealth Technology Identifies and develops peptide based therapeutics for cancer	Health Technology
Ci3 Management UG
Immatics US, Inc. Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer	Health Technology
Minaris Regenerative Medicine GmbH Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology Develops cell-based and gene therapy products	Health Technology
Tavia Consulting GmbH
iOmx Therapeutics AG iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients	Health Technology